cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance-Reference-Cited by-同舟云学术

cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance

Published:2005-12-02 Issue:1 Volume:96 Page:17-39
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Villeneuve David J.,Hembruff Stacey L.,Veitch Zachary,Cecchetto Melanie,Dew William A.,Parissenti Amadeo M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-005-9026-6.pdf

Reference215 articles.

1. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de RM, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein LP, Borresen-Dale AL Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874, 2001

2. Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Gokden M, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J, Jr. Pecorelli S Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling Br J Cancer 90:1814–1824, 2004

3. Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, Haferlach T Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients Leukemia 18:63–71, 2004

4. van't Veer LJ, Dai H., van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der KK, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH Gene expression profiling predicts clinical outcome of breast cancer Nature 415:530–536, 2002

5. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L., van, d V, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999–2009, 2002

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of comparative transcriptomic studies of cellular resistance to genotoxic stress;Mutation Research/Reviews in Mutation Research;2023-07

2. HIF-1–regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt/β-catenin pathway activation;Proceedings of the National Academy of Sciences;2021-10-27

3. Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy;Toxics;2021-09-22

4. Bioinformatics Analysis of TIMP1, HK2 and IGFBP7 as Potential Biomarkers and Therapeutic Targets of Paclitaxel Resistance in Breast Cancer;MIDDLE EAST J CANCER;2021

5. lncRNA profile study reveals the mRNAs and lncRNAs associated with docetaxel resistance in breast cancer cells;Scientific Reports;2018-12